(Q34996327)

5 August 2017

1 reference

title

Clinical and scientific advances in the Philadelphia-chromosome negative chronic myeloproliferative disorders (English)

1 reference

5 August 2017

Ruben A Mesa

1

1 reference

5 August 2017

language of work or name

1 reference

1 August 2002

1 reference

International Journal of Hematology

5 August 2017

published in

1 reference

5 August 2017

volume

76 Suppl 2

1 reference

5 August 2017

page(s)

193-203

1 reference

Prognostic factors and current practice in treatment of myelofibrosis with myeloid metaplasia: an update anno 2000.

5 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03165117

Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989.

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Prologue: polycythemia vera. The closing of the Wasserman-Polycythemia Vera Study Group era.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Angiogenesis in chronic myeloproliferative diseases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Letter: Bone-marrow responses in polycythemia vera

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. French Society of Bone Marrow Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Interferon-alpha-2 in the treatment of idiopathic myelofibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Current management of polycythemia vera

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Thrombopoietin: the primary regulator of platelet production

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Identification of increased protein tyrosine phosphatase activity in polycythemia vera erythroid progenitor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Polycythemia vera. V. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells: a possible defect of phosphatase activity in polycythemia vera

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

A chromosomal profile of polycythemia vera

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Resea

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

The Philadelphia chromosome negative chronic myeloproliferative disorders: a practical overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Recent progress in the pathogenesis and management of essential thrombocythemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera-associated pruritus

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Melphalan treatment in patients with myelofibrosis with myeloid metaplasia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Treatment of the myeloproliferative disorders with 32P.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Angiogenesis inhibitors generated by tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Pruritus in polycythaemia vera: prevalence, laboratory correlates and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Evidence of increased angiogenesis in patients with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Bone marrow and peripheral blood findings in patients with extreme thrombocytosis. A report of 63 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Interferon alfa: effects of long-term treatment for polycythemia vera

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Plasma interleukin-6 and C-reactive protein levels in reactive versus clonal thrombocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

STAT3 is constitutively active in some patients with Polycythemia rubra vera

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

No increased frequency of trisomies 8 and 9 by fluorescence in situ hybridization in untreated patients with essential thrombocythemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Platelet distribution width for differential diagnosis of thrombocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

p95(vav) associates with the type I interferon (IFN) receptor and contributes to the antiproliferative effect of IFN-alpha in megakaryocytic cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Interferon-alpha therapy in polycythemia vera and essential thrombocythemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Endogenous Erythroid Colony Formation by Peripheral Blood Mononuclear Cells from Patients with Myelofibrosis and Polycythemia Vera

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Clinical toxicity of interferons in cancer patients: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Diagnostic criteria of the myeloproliferative disorders (MPD): essential thrombocythaemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Therapeutic dilemmas: balancing the risks of bleeding, thrombosis, and leukemic transformation in myeloproliferative disorders (MPD)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Thalidomide in agnogenic and secondary myelofibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Determination of serum immunoreactive erythropoietin in the investigation of erythrocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Acute leukemia and myelodysplasia in polycythemia vera. A clinical study with long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

[Chronic myeloproliferative disorders. The new WHO classification]

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Strong inverse correlation between serum TPO level and platelet count in essential thrombocythemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Circulating haematopoietic progenitors in myelofibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Apoptosis of human erythroid colony‐forming cells is decreased by stem cell factor and insulin‐like growth factor I as well as erythropoietin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

The optimal management of polycythaemia vera

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Comparison of four serum-free, cytokine-free media for analysis of endogenous erythroid colony growth in polycythemia vera and essential thrombocythemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Bone marrow angiogenesis and progression in multiple myeloma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Expression of Bcl-x in erythroid precursors from patients with polycythemia vera

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

The use of bioinformatics to identify the genomic structure of the gene that encodes neutrophil antigen NB1, CD177

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Myelofibrosis with myeloid metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Endothelial dysfunction in patients with polycythaemia vera

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Diagnostic and differential criteria of essential thrombocythemia and reactive thrombocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Lack of interferon-alpha-induced tyrosine phosphorylation of Vav proto-oncogene in patients with myelofibrosis with myeloid metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Essential thrombocythemia and leukemic transformation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Diagnosis and treatment of thrombocythemia in myeloproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Essential thrombocythemia at diagnosis: causes of diagnostic evaluation and presence of positive diagnostic findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Megakaryocyte c-Mpl expression in chronic myeloproliferative disorders and the myelodysplastic syndrome: immunoperoxidase staining patterns and clinical correlates

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Radiation therapy for symptomatic hepatomegaly in myelofibrosis with myeloid metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Thalidomide therapy in compensated and decompensated myelofibrosis with myeloid metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Unexplained pulmonary hypertension in chronic myeloproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Bleeding and thrombosis in myeloproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Alpha interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Phosphatidylserine expression on the platelet membrane of patients with myeloproliferative disorders and its effect on platelet-dependent thrombin formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Long term treatment of myeloproliferative disease with interferon-alpha-2b: feasibility and efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

The determination of spontaneous megakaryocyte colony formation is an unequivocal test for discrimination between essential thrombocythaemia and reactive thrombocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Thalidomide treatment in myelofibrosis with myeloid metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Point mutations in the FLT3 gene in AML.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Molecular analysis of the erythropoietin receptor system in patients with polycythaemia vera

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Hemostatic gene polymorphisms and the prevalence of thrombotic complications in polycythemia vera and essential thrombocythemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Prognostic value of bone marrow angiogenesis in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Anagrelide for control of thrombocythemia in polycythemia and other myeloproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12430925

12 December 2020

Identifiers

DOI

10.1007/BF03165117

1 reference

Dimensions Publication ID

5 August 2017

1053306697

0 references

1 reference